NCT04490668

Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery

Association of Human Albumin With Anastomotic Leakage After Gastric Cancer Surgery

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,049 (actual)
• Sponsor: Ruijin Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.

Detailed description

Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical postoperative complication. Anastomotic leakage severely compromises the recovery after surgery. It increases the overall burden of patients and hospital resources. Postoperative mortality is higher in patients with anastomotic leakage. Human albumin is routinely administered after surgery with a unproven hypothesis that the human albumin is beneficial to prevent anastomotic leakage. We investigate whether the intravenously administered human albumin is beneficial to prevent anastomotic leakage after gastric cancer surgery.

Conditions

• Gastric Cancer
• Anastomotic Leak

Interventions

Type	Name	Description
BIOLOGICAL	Human albumin	Patients received intravenous human albumin after gastric cancer surgery. Overall quantity of human albumin were recorded.

Timeline

• Start date: 2016-01-01
• Primary completion: 2018-07-31
• Completion: 2019-12-30
• First posted: 2020-07-29
• Last updated: 2020-07-29